Literature DB >> 2843841

Prognostic significance of immunohistochemical parameters in breast carcinomas.

F Wrba1, A Reiner, E Markis-Ritzinger, J H Holzner, G Reiner, J Spona.   

Abstract

136 breast carcinomas were investigated immunohistochemically for alpha-lactalbumin (ALA), lactoferrin (Lfr), human milk fat globule membrane antigen (HMFG-2), transferrin receptor (TrfR), Ki-67 and epidermal growth factor receptor (EGFR). The relationships of pathologic features and steroid receptor status previously shown to be of prognostic significance and the immunohistochemical parameters were examined. It was found that estrogen receptor (ER) was inverse related to TrfR, Ki-67 and EGFR whereas progesterone receptor (PgR) was inverse correlated to Ki-67 solely. Tumor grading revealed significant correlations between TrfR, Ki-67 and HMFG-2 (inverse correlation). Tumor diameter showed correlation between Ki-67 solely. Moreover there were significant relationships between lymphoid infiltration and TrfR, Ki-67 and HMFG-2 (inverse correlation). The comparison of the immunohistochemical parameters showed correlations between Ki-67 and TrfR, Ki-67 and HMFG-2 (inverse correlation) as well as HMFG-2 and ALA. Therefore it is suggested that functional and tumor kinetic properties determined by HMFG-2, Ki-67 and TrfR may be an additional indicator with prognostic significance. On the other hand immunoreactivities of ALA in conjunction with HMFG-2 possibly indicates a subpopulation of breast carcinomas that may have to be investigated further. Moreover these results showed that lymphoid infiltration was correlated with Ki-67 reactivity as well as TrfR expression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843841     DOI: 10.1016/S0344-0338(88)80122-5

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  15 in total

1.  Prophylactic cancer vaccination by targeting functional non-self.

Authors:  Vincent K Tuohy; Ritika Jaini
Journal:  Ann Med       Date:  2011-06-09       Impact factor: 4.709

2.  Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction.

Authors:  R Prior; G Reifenberger; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.

Authors:  P Möller; G Mechtersheimer; M Kaufmann; G Moldenhauer; F Momburg; T Mattfeldt; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features.

Authors:  G Tuccari; A Rizzo; G Giuffrè; G Barresi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Potential use of vaccines in the primary prevention of breast cancer in high-risk patients.

Authors:  Matteo Lazzeroni; Davide Serrano
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

6.  A comparative study of cell proliferation markers in breast carcinomas.

Authors:  A S Leong; S Vinyuvat; C Suthipintawong; J Milios
Journal:  Clin Mol Pathol       Date:  1995-04

7.  Ultrastructural and immunohistochemical characteristics of lipid-rich carcinoma of the breast.

Authors:  F Wrba; A Ellinger; G Reiner; J Spona; J H Holzner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  An autoimmune-mediated strategy for prophylactic breast cancer vaccination.

Authors:  Ritika Jaini; Pavani Kesaraju; Justin M Johnson; Cengiz Z Altuntas; Daniel Jane-Wit; Vincent K Tuohy
Journal:  Nat Med       Date:  2010-05-30       Impact factor: 53.440

9.  Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.

Authors:  A Ieni; V Barresi; G Branca; G Giuffrè; M A Rosa; G Tuccari
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.